Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$61.03 USD

61.03
14,048,235

+1.04 (1.73%)

Updated Jun 13, 2024 04:00 PM ET

After-Market: $60.97 -0.06 (-0.10%) 5:40 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (231 out of 249)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?

According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Urmimala Biswas headshot

3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds

The Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain despite reimbursement challenges hurting the overall industry health.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed the most recent trading day at $87, moving -0.55% from the previous trading session.

CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks Now

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Shaun Pruitt headshot

Time to Buy CVS or Oak Street Health Stock on Potential Acquisition?

News of CVS Health (CVS) potentially acquiring Oak Street Health (OHS) for $10 billion broke this week and highlighted what could be another lucrative acquisition in 2023.

Shaun Pruitt headshot

5 Retail Stocks That Could Rally on Lower Inflation

Consumer data showing signs of deflation on a month-to-month basis is promising for the broader stock market. This is especially significant for the Retail and Wholesale sector and a stronger consumer could lead to more upside in these five stocks.

The Zacks Analyst Blog Highlights JPMorgan Chase, Chevron, Salesforce, CVS Health and FedEx

JPMorgan Chase, Chevron, Salesforce, CVS Health and FedEx are included in this Analyst Blog.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed at $89.75 in the latest trading session, marking a -0.99% move from the prior day.

Mark Vickery headshot

Top Research Reports for JPMorgan Chase, Chevron & Salesforce

Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Chevron Corporation (CVX) and Salesforce, Inc. (CRM).

Why CVS Health (CVS) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Mark Vickery headshot

World Bank Sees Slow Growth in 2023

The World Bank has slashed its 2023 growth projection from to +1.7% from +3% it just six short months ago.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed the most recent trading day at $91.98, moving -1% from the previous trading session.

CVS Health (CVS) Gains But Lags Market: What You Should Know

CVS Health (CVS) closed the most recent trading day at $93.45, moving +0.74% from the previous trading session.

CVS Health (CVS) Dips More Than Broader Markets: What You Should Know

CVS Health (CVS) closed at $93.02 in the latest trading session, marking a -0.58% move from the prior day.

Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet

Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $95, marking a -0.05% move from the previous day.

CVS Health (CVS) Stock Moves -0.42%: What You Should Know

CVS Health (CVS) closed the most recent trading day at $95.05, moving -0.42% from the previous trading session.

The Zacks Analyst Blog Highlights Verizon Communications, Honeywell International, CVS Health, Intuit and Incyte

Verizon Communications, Honeywell International, CVS Health, Intuit and Incyte are included in this Analyst Blog.

Sheraz Mian headshot

Top Research Reports for Verizon, Honeywell & CVS Health

Today's Research Daily features new research reports on 16 major stocks,including Verizon Communications Inc. (VZ), Honeywell International Inc. (HON) and CVS Health Corporation (CVS).

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Foot Locker (FL) Stock Up 8.7% on Q3 Earnings and Sales Beat

Foot Locker (FL) posts better-than-expected earnings for third-quarter fiscal 2022. FL's FLX membership program and omnichannel capabilities appear encouraging.